Sorafenib and sunitinib are oral tyrosine kinase inhibitors, commonly used in the treatment of metastatic renal cell carcinoma. Known adverse events associated with tyrosine kinase inhibitors include hypertension and palmarplantar erythrodysesthesia. We report two cases of acute pancreatitis associated with tyrosine kinase inhibitors.
MorganCTillettTBraybrookeJ. Management of uncommon chemotherapy-induced emergencies. Lancet Oncol2011; 12: 806–814.
4.
NitscheCJJamiesonNLerchMM. Drug induced pancreatitis. Best Pract Res Gastroenterol2010; 24: 143–155.
5.
SpanierBWTuynmanHAvan der HulstRW. Acute pancreatitis and concomitant use of pancreatitis associated drugs. Am J Gastroenterol2011; 106: 2183–2188.
6.
PezziliRFabbriDImbrognoA. Tyrosine kinase inhibitors, pancreatic hyperenzymemia and acute pancreatitis: a review. Recent Pat Inflamm Allergy Drug Discov2011; 5: 165–168.
7.
PezzelliRCorinaldesiRMoriselli-LabateAM. Tyrosine kinase inhibitors and acute pancreatitis. JOP2010; 11: 291–293.
8.
StrumbergDRichlyHHilgerRA. Phase I clinical and pharmacokinetic study of the novel raf kinase and vascular endothelial growth factor receptor inhibitor BAY 43-9006 in patients with advanced refractory solid tumors. J Clin Oncol2005; 23: 965–972.
9.
BrittenCDKabbinavarFHechtJR. A phase I and pharmacokinetic study of sunitinib administered daily for 2 weeks, followed by a 1-week off period. Cancer Chemother Pharmacol2008; 61: 515–524.
10.
AmarSWuKJTanWW. Sorafenib-induced pancreatitis. Mayo Clin Proc2007; 82: 516–522.
11.
LiMSrinivasS. Acute pancreatitis associated with sorafenib. South Med J2007; 100: 909–911.
KobayashiYKanemituTKamotoA. Painless acute pancreatitis associated with sorafenib treatment: a case report. Med Oncol2011; 28: 463–465.
14.
RuinemansGMBalemansCWiersma-van TillburgAJ. Letter to the editor: fatal necrotizing pancreatitis during combined treatment with erlotinib and sunitinib. Lung Cancer2010; 70: 364–365.
15.
NaranjoCABustoUSellersEM. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther1981; 30: 239–245.
